Related Experiment Video
Updated: Jun 10, 2026
09:15
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
CD73: a novel target for cancer immunotherapy
1Department of Medicine, Cancer Therapy & Research Center, University of Texas Health Sciences Center, San Antonio, Texas 78229, USA. Zhangb3@uthscsa.edu
Cancer Research
|August 5, 2010
Summary
Targeting CD73, an enzyme producing immunosuppressive adenosine, can enhance cancer immunotherapy. Inhibiting CD73 boosts T-cell responses against tumors, offering a promising strategy for improved cancer treatment outcomes.
Area of Science:
- Immunology
- Oncology
- Biochemistry
Background:
- Cancer immunotherapy faces challenges due to tumor-induced immune suppression.
- Tumor-derived CD73 produces adenosine, which inhibits anti-tumor T-cell responses.
Purpose of the Study:
- To investigate the role of CD73 in tumor-associated immune suppression.
- To evaluate the therapeutic potential of targeting CD73 for cancer treatment.
Main Methods:
- Utilized murine tumor models.
- Administered small molecule inhibitors and monoclonal antibodies targeting CD73.
Main Results:
- Targeting CD73 effectively reduced tumor growth.
- CD73 inhibition enhanced adaptive immune responses and T-cell activity within tumors.
Conclusions:
- Targeting CD73 is a viable strategy to overcome tumor-induced immunosuppression.
- CD73-targeted therapy can augment T-cell-based cancer treatments, potentially improving patient survival.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...